Landscape of Somatic Mutations Involving Lung Cancer Associated Genes in Non-Small Cell Lung Cancer (NSCLC) Patient-Derived Xenografts

被引:0
|
作者
Raghavan, Vibha [1 ]
Tam, Shirley [1 ]
Nhu-An Pham [1 ]
Li, Ming [1 ]
Shepherd, Frances [2 ,3 ]
Liu, Geoffrey [2 ,3 ]
Tsao, Ming [3 ,4 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Haematol, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Dept Pathol, Toronto, ON, Canada
关键词
Somatic mutations; PDX; whole-exome sequencing; NSCLC;
D O I
10.1016/j.jtho.2016.11.519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA17.06
引用
收藏
页码:S444 / S445
页数:2
相关论文
共 50 条
  • [21] Prognostic effect of single versus multiple somatic mutations in non-small cell lung cancer (NSCLC).
    Jao, Kevin
    Tomasini, Pascale
    Kamel-Reid, Suzanne
    Tsao, Ming Sound
    Korpanty, Gregorz J.
    Mascaux, Celine
    Liu, Geoffrey
    Leighl, Natasha B.
    Feld, Ronald
    Bradbury, Penelope Ann
    Ennis, Marguerite
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Rebecca Caeser
    Jacklynn V. Egger
    Shweta Chavan
    Nicholas D. Socci
    Caitlin Byrne Jones
    Faruk Erdem Kombak
    Marina Asher
    Michael H. Roehrl
    Nisargbhai S. Shah
    Viola Allaj
    Parvathy Manoj
    Sam E. Tischfield
    Amanda Kulick
    Maximiliano Meneses
    Christine A. Iacobuzio-Donahue
    W. Victoria Lai
    Umeshkumar Bhanot
    Marina K. Baine
    Natasha Rekhtman
    Travis J. Hollmann
    Elisa de Stanchina
    John T. Poirier
    Charles M. Rudin
    Triparna Sen
    Nature Communications, 13
  • [23] Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Caeser, Rebecca
    Egger, Jacklynn, V
    Chavan, Shweta
    Socci, Nicholas D.
    Jones, Caitlin Byrne
    Kombak, Faruk Erdem
    Asher, Marina
    Roehrl, Michael H.
    Shah, Nisargbhai S.
    Allaj, Viola
    Manoj, Parvathy
    Tischfield, Sam E.
    Kulick, Amanda
    Meneses, Maximiliano
    Iacobuzio-Donahue, Christine A.
    Lai, W. Victoria
    Bhanot, Umeshkumar
    Baine, Marina K.
    Rekhtman, Natasha
    Hollmann, Travis J.
    de Stanchina, Elisa
    Poirier, John T.
    Rudin, Charles M.
    Sen, Triparna
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [24] KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations
    Zhang, Xiaoshan
    Zhang, Ran
    Chen, Huiqin
    Wang, Li
    Ren, Chenghui
    Pataer, Apar
    Wu, Shuhong
    Meng, Qing H.
    Ha, Min Jin
    Morris, Jeffrey
    Xi, Yuanxin
    Wang, Jing
    Zhang, Jianhua
    Gibbons, Don L.
    Heymach, John, V
    Meric-Bernstam, Funda
    Minna, John
    Swisher, Stephen G.
    Roth, Jack A.
    Fang, Bingliang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (12): : 4464 - +
  • [25] PATIENT PREFERENCES FOR NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENTS
    Bridges, J. F.
    Mohamed, A.
    Finnern, H. W.
    Woehl, A.
    Hauber, A. B.
    VALUE IN HEALTH, 2011, 14 (07) : A459 - A459
  • [26] Somatic mutations of signaling genes in non-small-cell lung cancer
    Sanders, Heather R.
    Albitar, Maher
    CANCER GENETICS AND CYTOGENETICS, 2010, 203 (01) : 7 - 15
  • [27] Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts
    J. Rolff
    M. Becker
    J. Merk
    J. Hoffmann
    I. Fichtner
    Targeted Oncology, 2016, 11 : 507 - 514
  • [28] Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps
    Ilie, Marius
    Nunes, Manoel
    Blot, Lydia
    Hofman, Veronique
    Long-Mira, Elodie
    Butori, Catherine
    Selva, Eric
    Merino-Trigo, Ana
    Venissac, Nicolas
    Mouroux, Jerome
    Vrignaud, Patricia
    Hofman, Paul
    CANCER MEDICINE, 2015, 4 (02): : 201 - 211
  • [29] Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts
    Rolff, J.
    Becker, M.
    Merk, J.
    Hoffmann, J.
    Fichtner, I.
    TARGETED ONCOLOGY, 2016, 11 (04) : 507 - 514
  • [30] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390